Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Net Cash Flow (2022 - 2023)

Historic Net Cash Flow for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to $86.0 million.

  • Lexeo Therapeutics' Net Cash Flow rose 61157.96% to $86.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $44.2 million, marking a year-over-year change of. This contributed to the annual value of -$86.5 million for FY2024, which is 29590.3% down from last year.
  • Latest data reveals that Lexeo Therapeutics reported Net Cash Flow of $86.0 million as of Q4 2023, which was up 61157.96% from -$10.1 million recorded in Q3 2023.
  • Lexeo Therapeutics' Net Cash Flow's 5-year high stood at $86.0 million during Q4 2023, with a 5-year trough of -$18.5 million in Q1 2023.